2MatsumotoM, Furihata M, Ishikawa T, et al. Comparison of deregulated expression of cyclinD1 and cyclinE with that of cyclin-dependent Kinase 4(CDK4) and CDK2 in human oesophageal squamous cell carcinoma[J].Br J Cancea, 1999,80:256.
3Anayama T, Furihata M,Ishikawa T, et al. Positive correlation between P27kipl expression and proexpression of human esophageal squamous cell carcinoma[J]. Int J cancer, 1998,79:439.
3Scott K A, Walker R A. Lack of cyclin E immunoreactivity in non-malignant breast and association with proliferation in breast cancer[J]. Br J Cancer, 1997,76(10):1288-1292.
4Beauchamp R D, Sheng H M, Shao J Y, et al. Intestinal cell cycle regulations. Interactions of CyclinD1, Cdk4, and p21Cip1[J]. Ann Surg, 1996,223(5):620-627.
5Buschges R, Weber R G, Actor B, et al. Amplification and expression of Cyclin D genes (CCND1, CCND2 and CCND3) in human malignant gliomas[J]. Brain Pathol, 1999,9(3):435-442.
6Bortner D M, Rosenberg M P. Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E[J]. Mol Cell Biol, 1997,17(1):453-459.
7Ohtani K, DeGregori J, Nevins J R. Regulation of the cyclin E gene by transcription factor E2F1[J]. Proc Natl Acad Sci U S A, 1995,92(26):12146-12150.
